As of 03-Jul, Lasa Supergenerics Ltd is experiencing a price increase, with the current price at 11.79, reflecting a change of 0.23 or 1.99% upward. The stock has shown a significant performance improvement recently, gaining 31.58% over the last seven days and outperforming its sector by 1.51% today. Despite this recent uptick, the stock has had a challenging year, with a year-to-date decline of 54.37% and a one-year return of -48.22%. The company reported very positive results in March, with a 71.52% growth in net sales, but it also faces long-term fundamental weaknesses, including a -186.25% CAGR growth in operating profits over the last five years and a low return on equity of 3.54%, indicating low profitability.
In the broader market context, Lasa Supergenerics Ltd's short-term performance contrasts sharply with the benchmark, as it has gained 20.31% over the past week while the Sensex has declined by 0.62%. However, the stock's long-term performance remains concerning, as it has consistently underperformed against the benchmark over the last three years. The company's weak ability to service its debt and negative operating profits contribute to a risky investment profile, despite the recent positive sales growth. This combination of short-term gains and long-term challenges creates a complex picture for investors considering the stock.